Argo Biotech ApS: Financial statements 2022
CVR: 41133937
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Argo Biotech ApS (CVR 41133937) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -80 compared with DKK -96 the year before. Equity in the 2022 report amounted to DKK 12,258. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -80
- Equity
- DKK 12,258
- Total Assets
- DKK 12,258
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 0 | -80 | 12K | - |
| 2021 | 0 | 0 | -96 | 12K | - |
| 2020 | 0 | -27K | -27K | 13K | - |
Official annual report
Keep an eye on Argo Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Argo Biotech ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -96.
About Argo Biotech ApS
Argo Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company has been dissolved on 16 August 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -80 compared with DKK -96 the year before. Equity in the 2022 report amounted to DKK 12,258.